University of Texas Southwestern Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Texas Southwestern Medical Center sits in the top decile of US sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count).

837 total trials 162 currently recruiting 503 completed early-phase tilt top decile by trial count

University of Texas Southwestern Medical Center: 837 sponsored US clinical trials, 162 recruiting.

University of Texas Southwestern Medical Center sponsors 837 registered US clinical trials on ClinicalTrials.gov, 162 of them currently recruiting, and 503 completed. 126 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 9 trials.

Top-decile sponsor footprint

University of Texas Southwestern Medical Center ranks in the top decile of sponsors by registered trial count (#39 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

503 of 608 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

837 total, page 14 of 17

COMPLETED

Epigenetic Testing for Breast Cancer Risk Stratification

NCT01501656

TERMINATED NA

A Study of the Laparoscopically-placed Adjustable Gastric Band for the Management of Obesity in Adolescent Patients

NCT01409928

COMPLETED

Characterization of the Functional and Structural Development of the Human Neonatal Brain From 30 Wks to 45 Wks ga

NCT02170142

COMPLETED Phase 4

Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation

NCT01515995

COMPLETED Phase 4

Attenuation of Corticosteroid Induced Hippocampal Changes

NCT01656187

COMPLETED Phase 2

Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus

NCT02021513

COMPLETED Phase 1

Clinical Trial of ARQ 761 in Advanced Solid Tumors

NCT01502800

COMPLETED Phase 4

QR-Bromocriptine as an Adjunct to Insulin and Metformin in the Treatment of Type 2 Diabetes

NCT01474018

COMPLETED Phase 2

Hippocampal-Avoiding Whole Brain Irradiation With Simultaneous Integrated Boost for Treatment of Brain Metastases

NCT01414738

TERMINATED Phase 2

Radioactive Iodine Implants for Pan-invasive Pituitary Macroadenomas

NCT01444209

TERMINATED NA

Using Rapid Cine-MRI for Monitoring Moving and Deforming Tumors

NCT01421784

COMPLETED Phase 3

Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients

NCT02478580

COMPLETED

Study of Venous Endothelial Cells in Rheumatoid Arthritis

NCT02468986

COMPLETED Phase 2

Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression

NCT01407094

TERMINATED

Circulating Tumor Cells in Prostate Cancer Patients

NCT01414712

TERMINATED Phase 1

Effects of IGF-I in HIV Metabolic Disease

NCT01329744

COMPLETED

Mechanisms and Treatment of Intradialytic Hypertension - Sodium

NCT01371890

COMPLETED NA

Near-Infrared Spectroscopy for Pediatric Acute Scrotum and Testicular Torsion

NCT01812109

COMPLETED Phase 1

Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers

NCT01321151

COMPLETED Phase 1

Rilonacept in Diabetes Mellitus Type 1: Safety Study

NCT00962026

COMPLETED NA

Efficacy Study of Polyethylene Glycol 3350-electrolyte Solution (GoLYTELY®) Versus Lactulose in Patients With Hepatic Encephalopathy.

NCT01283152

COMPLETED Phase 1

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

NCT01264705

COMPLETED Phase 1

Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal Cancer

NCT01407107

COMPLETED Phase 4

Airway Responses During Desflurane Anesthesia Via a Laryngeal Mask Airway: Effects of Fentanyl Pretreatment

NCT01277861

COMPLETED NA

A Randomized Trial of Effects of Parent Mentors on Insuring Minority Children

NCT01264718

COMPLETED Phase 2

Pharmacokinetics of Linezolid in Children With Cystic Fibrosis

NCT00625703

TERMINATED NA

Dilute Bleach Baths in Pediatric Patients With Atopic Dermatitis

NCT01286220

COMPLETED Phase 1

Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast Cancer

NCT01162200

COMPLETED NA

Therapeutic Stockings to Prevent Foot Ulcers

NCT01221194

COMPLETED NA

Instant Total Contact Cast to Heal Diabetic Foot Ulcers

NCT01221207

COMPLETED

Reliability and Diagnostic Accuracy of an Alternate Lachman's Test Performed in a Prone Position

NCT01301014

TERMINATED Phase 1

Effects of Metreleptin in Type 1 Diabetes Mellitus

NCT01268644

COMPLETED NA

Trial of a Limited Versus Traditional Oxygen Strategy During Resuscitation in Premature Newborns

NCT01697904

COMPLETED Phase 4

Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients

NCT01501929

COMPLETED Phase 1

Stereotactic Body Radiation Therapy (SBRT) for Patients With Hepatic Metastases

NCT01162278

COMPLETED Phase 4

Antidepressant Treatment at an Inner City Asthma Clinic

NCT01324700

COMPLETED Phase 3

Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence

NCT00223236

COMPLETED NA

Exercise as a Treatment for Substance Use Disorders Protocol

NCT01141608

COMPLETED

Diabetes and Gastric By- Pass

NCT01153516

COMPLETED Phase 4

Reversing Corticosteroid Induced Memory Impairment

NCT01142310

COMPLETED NA

An Intervention Promoting HPV Vaccination in Safety-net Clinics

NCT01729429

COMPLETED NA

Ultrasound-guided Transversus Abdominis Plane Block After Hysterectomy

NCT01153503

COMPLETED NA

Aerobic Exercise Training in Mild Cognitive Impairment Study

NCT01146717

COMPLETED Phase 4

Study Using Pregnenolone to Treat Bipolar Depression

NCT01409096

COMPLETED NA

Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy

NCT01074840

COMPLETED NA

"A Randomized, Controlled, Evaluator-blinded Pilot Study to Evaluate the Effect of Automated Text Message Reminders on Patient Compliance With Topical Medications and Its Efficacy on Skin Disease Control in Adolescents and Adults With Mild to Moderate Acne"

NCT01082523

COMPLETED NA

Pathophysiology of Uric Acid Nephrolithiasis

NCT00904046

COMPLETED Phase 1

Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)

NCT01014403

COMPLETED Phase 4

Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers

NCT01090141

COMPLETED Phase 4

A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary Care

NCT00939250

← Previous Page 14 of 17 Next →

Phase Distribution

PhaseTrial count
Phase 1 106
Phase 2 122
Phase 3 28
Phase 4 98

What is open in the University of Texas Southwestern Medical Center pipeline

162 recruiting of 837 indexed (19% open); 503 completed (60%).

Phase mix: 126 late (III/IV) vs 228 early (I/II) (early-phase heavy).

Top condition: Hypertension (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Texas Southwestern Medical Center: open-pipeline peers nationwide

Peers matched on 837 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 02004006008001,000 14%16%18%20%22% Total trials Recruiting share University of Texas Southwestern Medical CenterUniversity of UtahUniversity of ChicagoIndiana UniversityDana-Farber Cancer InstituteCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalAnn & Robert H Lurie Children's Hospital of ChicagoVanderbilt University Medical Center
University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Texas Southwestern Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 837 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this University of Texas Southwestern Medical Center page

837 registered trials is a research-attention snapshot, not an endorsement of University of Texas Southwestern Medical Center or any single study.

  • 162 of University of Texas Southwestern Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Hypertension is the condition University of Texas Southwestern Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Texas Southwestern Medical Center pipeline card: 837 registered trials from official public datasets.Report a data error.